David Phelps is an Honorary Clinical Lecturer at Imperial College London and Gynaecological Oncology Sub-Specialty Fellow at the West London Gynaecological Cancer Centre, Hammersmith Hospital. After completing undergraduate studies in Biology, David went on to complete his Bachelor of Medicine and Surgery (BM) at the University of Southampton in 2008. Since gaining his national training number in Obstetrics and Gynaecology he has completed his post graduate membership examinations and has been a member of the Royal College of Obstetricians and Gynaecologists (MRCOG) since 2014. He was awarded his PhD from Imperial College in 2018 and is currently completing his sub-specialist clinical training to become a consultant surgeon in gynaecological-oncology.
David joined Imperial College in 2014 as a Cancer Research UK funded Clinical Research Fellow to undertake his PhD research, under the supervision of Dr Sadaf Ghaem-Maghami and Professor Bob Brown. David's research focuses on personalised medicine and the discovery of clinical, epigenetic and phospholipid biomarkers that have the potential to personalise surgical care in patients with ovarian cancer. His collaboration with Professor Zoltan Takats enabled him to trial the use of the Surgical Intelligent Knife (iKnife) in gynae-oncology patients. David's iKnife results have been well received, with him presenting at local, national and international conferences. His research has been recognised by awards including the Herbert Reiss Trainees Prize, Blair-Bell research competition prize and RCOG World Congress prize..
et al., 2018, The surgical intelligent knife distinguishes normal, borderline and malignant gynaecological tissues using rapid evaporative ionisation mass spectrometry (REIMS), British Journal of Cancer, Vol:118, ISSN:0007-0920, Pages:1349-1358
et al., 2017, Methylation of MYLK3 gene promoter region: a biomarker to stratify surgical care in ovarian cancer in a multi-centre study, British Journal of Cancer, Vol:116, ISSN:1532-1827, Pages:1287-1293
et al., 2016, Clinical use of programmed cell death-1 (PD-1) and its ligand (PD-L1) expression as discriminatory and predictive markers in ovarian cancer, Clinical Cancer Research, Vol:23, ISSN:1557-3265, Pages:3453-3460
et al., 2017, PROOF OF CONCEPT: CAN THE INTELLIGENT SURGICAL KNIFE DIAGNOSE ENDOMETRIAL CANCER?, LIPPINCOTT WILLIAMS & WILKINS, Pages:1152-1152, ISSN:1048-891X
Phelps DL, A tumour-DNA methylation biomarker to predict response to treatment in patients with ovarian cancer; a multi-centre study., Royal College of Obstetricians and Gynaecologists - World Congress